Free Trial
NASDAQ:MDCX

Medicus Pharma (MDCX) Stock Price, News & Analysis

Medicus Pharma logo
$4.18 -0.09 (-2.11%)
As of 03:59 PM Eastern

About Medicus Pharma Stock (NASDAQ:MDCX)

Key Stats

Today's Range
$4.10
$4.55
50-Day Range
$2.61
$4.52
52-Week Range
$1.80
$6.00
Volume
27,457 shs
Average Volume
51,570 shs
Market Capitalization
$56.13 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$12.00
Consensus Rating
Strong Buy

Company Overview

Medicus Pharma Ltd is a biotech/life sciences company focused on accelerating the clinical development programs of novel and disruptive therapeutics assets. Medicus Pharma Ltd is based in Toronto, Ontario.

Receive MDCX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Medicus Pharma and its competitors with MarketBeat's FREE daily newsletter.

MDCX Stock News Headlines

Trump wipes out trillions overnight…
Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out nearly $5 trillion in wealth from the S&P 500 and $6.4 trillion from the Dow Jones… Not to mention the countless trillions of dollars lost in every market around the world… leaving the major political powers scrambling in fear of Trump’s next move.
Medicus Pharma Ltd (MDCX)
See More Headlines

MDCX Stock Analysis - Frequently Asked Questions

Medicus Pharma's stock was trading at $2.43 at the start of the year. Since then, MDCX stock has increased by 72.0% and is now trading at $4.18.
View the best growth stocks for 2025 here
.

Medicus Pharma Ltd. (NASDAQ:MDCX) issued its quarterly earnings data on Friday, March, 28th. The company reported ($0.18) EPS for the quarter, topping the consensus estimate of ($0.32) by $0.14.

Medicus Pharma (MDCX) raised $4 million in an IPO on Thursday, November 14th 2024. The company issued 1,000,000 shares at $4.13 per share. Maxim Group LLC served as the underwriter for the IPO and Brookline Capital Markets was co-manager.

Top institutional shareholders of Medicus Pharma include Interchange Capital Partners LLC (12.39%) and Private Advisor Group LLC (0.42%).

Shares of MDCX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Last Earnings
3/28/2025
Today
5/06/2025
Next Earnings (Estimated)
6/27/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:MDCX
Previous Symbol
NASDAQ:MDCX
Fax
N/A
Employees
N/A
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$12.00
High Stock Price Target
$14.00
Low Stock Price Target
$10.00
Potential Upside/Downside
+187.1%
Consensus Rating
Strong Buy
Rating Score (0-4)
3.50
Research Coverage
4 Analysts

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
N/A
Market Cap
$56.13 million
Optionable
N/A
Beta
N/A
13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.

Get This Free Report

This page (NASDAQ:MDCX) was last updated on 5/6/2025 by MarketBeat.com Staff
From Our Partners